跳至主要内容
临床试验/DRKS00013094
DRKS00013094招募中不适用

Early and continuously raising of blood pressure may prevent fluctuations of cerebral blood flow in very low birth weight infants (VLBW) especially in VLBW infants without cerebral autoregulation!

Kinderklinik Heidelberg, Abteilung Neonatologie0 个研究点目标入组 20 人开始时间: 2017年10月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
23 Pregnancy 至 30 Pregnancy(—)
性别
All

入选标准

  • preterm infant with a gestational age less than 30 weeks

排除标准

  • heart failure

研究者

发起方
Kinderklinik Heidelberg, Abteilung Neonatologie

相似试验

招募中
1 期
THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN patients with moderate to severe chronic Kidney disease: an open lapel, cluster randomized controlled, phase 3 trialncontrolled Hypertension IN patients with moderate to severe chronic Kidney diseaseMedDRA version: 21.1Level: LLTClassification code: 10066860Term: Uncontrolled hypertension Class: 10047065MedDRA version: 21.1Level: PTClassification code: 10064848Term: Chronic kidney disease Class: 100000004857
CTIS2022-501494-39-00Centre Hospitalier Regional Universitaire De Tours720
已完成
不适用
Reflex effects of a spinal adjustment on blood pressureBlood pressure in chiropractic patientsBlood - Normal development and function of platelets and erythrocytes
ACTRN12607000020482Kelly Holt100
已完成
不适用
Chia seed supplementation improved systolic blood pressure in people with type-2 diabetes&#45blood pressure&#45fasting glucose&#44insulin&#44HbA1c and lipid profile&#45body weight changesChia seeds&#44blood pressure&#44glycated hemoglobin&#44body weight
TCTR20190727003Kuwait University44
招募中
不适用
Clinical implication of initial blood pressure decrease on sit-to-stand orthostatic stress test: A prospective observational studyAtherosclerotic disease
JPRN-UMIN000015195The Kobayashi Medical Clinic1,000
进行中(未招募)
不适用
Prevención de la progresión de la hipertensión portal en la cirrosis compensada mediante el uso de vasodilatadores hepáticos selectivos. Estudio multicéntrico, aleatorizado y doble-ciego - SIMPROEl objetivo de estudio es valorar el efecto de las estatinas, en su efecto vasodilatador selectivo hepático, en la prevención de la progresión de la hipertensión portal ( con un gradiente de presión entre 6 y 10 mmHg) en pacientes con cirrosis hepática compensada.MedDRA version: 12.1Level: HLTClassification code 10036201Term: Portal hypertensions
EUCTR2010-021593-11-ESINSTITUT DE RESERCA.HSCSP
Early and continuously raising of blood pressure may... | 临床试验